Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 11:47:55 2017-02-27 pm EST 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.66M 2.49M 2.28M 4.29M 293M 4.36M 29.19M 11.46M 147M 11.57M 11.31M 486M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.14M 2.93M 2.69M 5.06M 345M 5.14M 34.39M 13.5M 173M 13.63M 13.33M 572M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 2020-01-27
Director TitleAgeSince
Director/Board Member 60 2020-01-16
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+0.99%+1.78%+5.07%+16.49% 49.47B
+3.71%+9.40%+486.14%+579.98% 43.97B
+5.60%+10.21%+20.85%+81.78% 39.6B
+2.70%+1.57%+32.71%+9.07% 39.29B
+2.21%+6.75%+20.20%+54.40% 32.43B
+2.23%+4.71% - - 16.84B
+0.97%+2.35%+35.99%+124.45% 16.49B
-0.11%+2.41%+5.03%+20.47% 14.01B
+0.75%+15.04%+79.84%+29.70% 12.77B
Average +11.90%+15.69%+85.73%+114.54% 26.49B
Weighted average by Cap. +2.54%+6.10%+105.13%+138.67%

Financials

2017 2018
Net sales 16.01K 13.85K 12.93K 11.86K 22.31K 1.52M 22.67K 152K 59.55K 764K 60.12K 58.8K 2.52M 124 107.26 100.16 91.89 172.83 11.8K 175.57 1.18K 461.26 5.92K 465.64 455.45 19.56K
Net income -481K -416K -388K -356K -670K -45.77M -681K -4.56M -1.79M -22.94M -1.81M -1.77M -75.85M -976K -844K -788K -723K -1.36M -92.85M -1.38M -9.25M -3.63M -46.54M -3.66M -3.58M -154M
Net Debt 497K 430K 401K 368K 692K 47.27M 703K 4.71M 1.85M 23.7M 1.87M 1.82M 78.34M 548K 474K 443K 406K 764K 52.18M 776K 5.2M 2.04M 26.16M 2.06M 2.01M 86.47M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-